NCT06996184View on ClinicalTrials.gov

Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 27, 2025

Primary Completion Date

July 1, 2025

Study Completion Date

July 2, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

Vamifeport (PR formulation)

Vamifeport will be administered orally

Trial Locations (1)

LS11 9E

Investigator Site 82600083, Leeds

Sponsors

Lead Sponsor

CSL Behring
All Listed Sponsors
lead

CSL Behring

INDUSTRY

NCT06996184 - Effect of Food on the Oral Bioavailability of a Prolonged-release Formulation of Vamifeport in Healthy Adults | Biotech Hunter | Biotech Hunter